Discovering if You're High Risk at Diagnosis
Discovering if You're High Risk at Diagnosis image
Jul 22, 2021 / 01:00PM - 02:00PM EDT
Newly Diagnosed Myeloma Patients Chapter

Event Description

Knowing what type of myeloma you are facing allows you to better fight it. High-risk genetic myeloma often requires a more aggressive treatment regimen than those who are standard-risk patients. Learn from Skyline Dx representatives about their new diagnostic test. This test is one way that newly diagnosed patients can discover their genetic risk and become more empowered to face it head on. Learn with us and come with your questions.


SkylineDx is a biotechnology company, focused on the research & development of molecular diagnostics in oncology and inflammatory diseases. The company is headquartered in Rotterdam (the Netherlands) and complemented with a field medical and scientific affairs team in the US and a CAP/CLIA certified laboratory in San Diego (California). SkylineDx uses its expertise to bridge the gap between academically discovered gene expression signatures and commercially available diagnostic products with high clinical utility, assisting healthcare professionals in accurately determining the type or status of the disease or predict a patient’s response to treatment. Based on test results, healthcare professionals can tailor the treatment approach to the individual patient.

Schedule & Agenda

person
Introductions
01:00PM
Audrey Burton-Bethke
Audrey welcomes everyone, shares the event agenda, and introduces our featured speaker.
person
Presentation
01:05PM
Arjan van Manen
Arjan presents about SkylineDx's new diagnostic test and how it can help newly diagnosed patients discover their genetic risk.
person
Q&A
01:35PM
Audience
Ask your questions about SkylineDx's new diagnostic test, the presentation, and related topics.

Speakers & Moderators

The panelist Audrey Burton-Bethke
Audrey Burton-Bethke

Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.

Read Bio
The panelist Arjan van Manen
Arjan van Manen

Arjan van Manen is the EVP of Business and Commercial Development at SkylineDx BV. He is a strong commercial professional with a track record in Clinical Research, International Marketing Strategy, Market Access, Commercial Excellence Programs, and Business Development. His primary fields of expertise are oncology/ hematology and surgery. He also has experience in the pharmaceutical, medical device, and diagnostic fields. Prior to working at SkylineDx, he worked with organizations including Bristol-Myers Squibb and Takeda Pharmaceuticals. He is fluent in Dutch, German, and English.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

+1 800 709 1113

email

Support@healthtree.org

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Legend Biotechnologies
Bristol Myers Squibb
Abbvie
Genentech
GSK
Janssen Oncology

Follow Us

facebook instagram twitter youtube

Copyright © 2022 HealthTree Foundation. All Rights Reserved.

The HealthTree Foundation for Multiple Myeloma (formerly know as Myeloma Crowd) is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811

 https://www.guidestar.org/profile/45-5354811